NASDAQ:FATE   Fate Therapeutics, Inc.
Diamond reversal in play, targets $82 ---> $86
Comment:
called diamond a little early, adjust the trendline down to $71, if it cant hold it will invalidate my diamond reversal thesis :D
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.